Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Ischemic Mitral Regurgitation
NCT01979965Phase 4Unknown
- Sponsor
- University Cardiology
- Start
- Nov 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in Ischemic mitral regurgitation (IMR), sponsored by University Cardiology. Status: unknown.
02
Drugs
ranolazine
03
Conditions
Ischemic mitral regurgitation (IMR)
Beyond the preview
Go deeper on NCT01979965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979965.